The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127098991 12709899 1 I 201406 20150721 20160902 20160902 EXP JP-GLAXOSMITHKLINE-JP2015JPN103946 GLAXOSMITHKLINE KIKUI S, MIYAHARA J, SUGIYAMA H, KASHIWAYA Y, TAKESHIMA T.. EFFECTIVE MICROVASCULAR DECOMPRESSION OF THE TRIGEMINAL NERVE IN A PATIENT WITH SHORT-LASTING UNILATERAL NEURALGIFORM HEADACHE ATTACKS WITH CONJUNCTIVAL. BRAIN AND NWERVE. 2016;68(8):951-955 43.00 YR M Y 72.00000 KG 20160902 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127098991 12709899 1 PS LAMICTAL LAMOTRIGINE 1 Oral 50 MG, 1D Y 20241 50 MG TABLET QD
127098991 12709899 2 SS LAMICTAL LAMOTRIGINE 1 Oral 100 MG, 1D Y 20241 100 MG TABLET QD
127098991 12709899 3 SS LAMICTAL LAMOTRIGINE 1 Oral 150 MG, 1D Y 20241 150 MG TABLET QD
127098991 12709899 4 SS LAMICTAL LAMOTRIGINE 1 Oral 200 MG, 1D Y 20241 200 MG TABLET QD
127098991 12709899 5 SS TOPIRAMATE. TOPIRAMATE 1 Oral 50 MG, 1D Y 0 50 MG QD
127098991 12709899 6 SS TOPIRAMATE. TOPIRAMATE 1 Oral 100 MG, 1D Y 0 100 MG QD
127098991 12709899 7 SS TOPIRAMATE. TOPIRAMATE 1 Oral 50 MG, 1D Y 0 50 MG QD
127098991 12709899 8 C CARBAMAZEPINE. CARBAMAZEPINE 1 400 MG, 1D 0 400 MG QD
127098991 12709899 9 C GABAPENTIN. GABAPENTIN 1 1200 MG, 1D 0 1200 MG QD
127098991 12709899 10 C GABAPENTIN. GABAPENTIN 1 1800 MG, 1D 0 1800 MG QD
127098991 12709899 11 C SUMATRIPTAN. SUMATRIPTAN 1 3 MG, 1D 0 3 MG QD
127098991 12709899 12 C INDOMETACIN INDOMETHACIN 1 75 MG, 1D 0 75 MG QD
127098991 12709899 13 C LIDOCAINE. LIDOCAINE 1 2 UNK, UNK 0
127098991 12709899 14 C LIDOCAINE. LIDOCAINE 1 2 UNK, UNK 0

Indications of drugs used

no results found

Outcome of event

Event ID CASEID OUTC COD
127098991 12709899 HO
127098991 12709899 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127098991 12709899 Dermatitis bullous
127098991 12709899 Drug eruption
127098991 12709899 Hepatic function abnormal
127098991 12709899 Pyrexia
127098991 12709899 Rash pruritic
127098991 12709899 SUNCT syndrome
127098991 12709899 Stevens-Johnson syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127098991 12709899 1 201405 201405 0
127098991 12709899 2 201405 201405 0
127098991 12709899 3 201405 201406 0
127098991 12709899 4 201406 201406 0
127098991 12709899 5 201406 201406 0
127098991 12709899 6 201406 201406 0
127098991 12709899 7 201406 201412 0
127098991 12709899 10 201412 0
127098991 12709899 11 201405 0
127098991 12709899 13 201405 201405 0
127098991 12709899 14 201412 201412 0